$YUM Balance Sheet | Understand Stock

$YUM

$149.47 -$0.23 (0.15%) Close

$YUM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current Assets
Cash and cash equivalents
Accounts and notes receivable, net
Prepaid expenses and other current assets
Prepaid Expense and Other Assets, Current
Disposal Group, Including Discontinued Operation, Assets
Total Current Assets

Property, plant and equipment, net
Goodwill
Intangible assets, net
Other assets
Deferred Income Taxes
Total Assets
LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and other current liabilities
Income taxes payable
Short-term borrowings
Disposal Group, Including Discontinued Operation, Liabilities
Total Current Liabilities
Long-term debt
Other liabilities and deferred credits
Total Liabilities
Shareholders' Equity
Common Stock, no par value, 750 shares authorized; 280 shares issued in 2024 and 281 issued in 2023
Accumulated Deficit
Accumulated other comprehensive loss
Total Shareholders' Deficit
Total Liabilities and Shareholders' Deficit
Common Stock, No Par Value
Common Stock, Shares Authorized
Common Stock, Shares, Issued

Comments